Newsweek

Psilocybin Reduces Anxiety in Cancer Patients

It’s too soon to be sure, but the effect of the drug could be permanent.
Psilocybin, the active ingredient in psychoactive or "magic" mushrooms, has been shown to reduce anxiety and depression in cancer patients.
psilocybe-semilanceata

In 2010, doctors diagnosed Dinah Bazer with ovarian cancer. After treatment and chemotherapy, it went into remission, but as the months wore on, she became increasingly terrified that the disease might return. Two years after diagnosis, she felt worse than ever. “The fear was eating me alive,” she says. “It was destroying my life.”

She heard about a study at New York University, where physicians were using psilocybin—the active ingredient in psychoactive mushrooms of the genus Psilocybe, referred to by some as magic mushrooms—to treat cancer patients struggling with extreme anxiety and depression. After being carefully screened, Bazer entered the study and got to know the psychologists running it during several therapy sessions. Then, one day, she was given a moderately high dose of psilocybin.

After feeling the drug kick in, she felt like she was lost at sea, afraid. One of her therapists held her hand, and this gave her mooring. She had a vision of her fear as a dark mass under her ribcage. It was consuming her. She became angry, furious. “Get the fuck out!” she screamed.  

A moment later, the fear was gone. “It completely evaporated,” she says.

Next, she felt transported to a place where she felt nothing but love. “I’m an atheist, but the best way to

You’re reading a preview, subscribe to read more.

More from Newsweek

Newsweek12 min read
The Inconceivable Search For Sperm
SINGLE WOMEN AND LGBTQ+ COUPLES are increasingly pursuing pregnancy via known donors—people they find on the internet, in Facebook groups and through dating-like apps. In her own quest to become a solo mother by choice, investigative journalist Valer
Newsweek3 min read
Newsweek US
GLOBAL EDITOR IN CHIEF _ Nancy Cooper VICE PRESIDENT, DIGITAL _ Laura Davis DIRECTOR OF OPERATIONS _ Melissa Jewsbury OPINION EDITOR _ Batya Ungar-Sargon GLOBAL PUBLISHING EDITOR _ Chris Roberts SENIOR EDITOR-AT-LARGE _ Josh Hammer EDITORIAL Managi
Newsweek5 min read
‘Deadly Risk’ of Fat-Loss Drugs
“MIRACLE” FAT-MELTING DRUG OZEMPIC HAS been linked in a study to a series of rare but potentially fatal psychiatric episodes, scientists have warned. The injectable prescription drug was developed to manage blood sugar levels in patients with Type 2

Related